📊 Score Breakdown
Offering Ability
60
Cash Runway
40
Float Risk
20
Warrant Exposure
15
Convertible Debt—
🌦️ Dilution Forecast
🌥️
Advisory
Moderate dilution signals present
32%
🔁 Convertible Conversion
40%
• Significant convertible debt: 24% potential dilution
• Elevated convertible risk (60/100)
🔄 Reverse Split
30%
• 50-day avg $1.19 approaching $1 threshold
💰 Capital Raise
18%
• Active ATM program with $3M remaining capacity
💹 Market Data
Market Cap$4.34M
Shares Outstanding10.31M
Float9.76M
Cash$7.94M
Debt$358.1K
Short InterestN/A
🏛 Institutional Holdings
QoQ: ↓ 67.8% shares (2025Q4 vs prior)
19 institutional holders · 448.1K shares
#1
DRW Securities, LLC
124.8K shares
#2
VANGUARD GROUP INC
85.5K shares
#3
GEODE CAPITAL MANAGEMENT, LLC
80.4K shares
+ 16 more holders Sign up free to view →
📉 Short Interest
Short Interest809.1K
Days to Cover5.1
% of Float8.3%
FINRA data as of Apr 15, 2026
📁 Recent SEC Activity
xbrl
XBRL WARRANT
Dec 31, 2025
xbrl
XBRL CONVERTIBLE
Dec 31, 2024
EFFECT
EFFECT
Apr 02, 2026
EFFECT
EFFECT
Apr 02, 2026
EFFECT
EFFECT
Apr 02, 2026
Full SEC filing analysis available with free account →
📰 Recent News
No recent news
🔬 More Research for SNGX
📊 SNGX FDA Catalyst Timeline & Biotech Grade — BiotechSigns
📡 SNGX Signal Convergence & Dark Pool Activity — StonkWhisper
Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.